A single intravenous AAV9 injection mediates bilateral gene transfer to the adult mouse retina.
Widespread gene delivery to the retina is an important challenge for the treatment of retinal diseases, such as retinal dystrophies. We and others have recently shown that the intravenous injection of a self-complementary (sc) AAV9 vector can direct efficient cell transduction in the central nervous...
Main Authors: | Alexis-Pierre Bemelmans, Sandra Duqué, Christel Rivière, Stéphanie Astord, Mélissa Desrosiers, Thibault Marais, José-Alain Sahel, Thomas Voit, Martine Barkats |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3626698?pdf=render |
Similar Items
-
Efficacy and biodistribution analysis of intracerebroventricular administration of an optimized scAAV9-SMN1 vector in a mouse model of spinal muscular atrophy
by: Nicole Armbruster, et al.
Published: (2016-01-01) -
AAV capsid bioengineering in primary human retina models
by: Adrian Westhaus, et al.
Published: (2023-12-01) -
Cell-mediated inflammatory response to AAV gene therapy in the retina
by: Chandler, LC, et al.
Published: (2020) -
Correction: AAV9 Targets Cone Photoreceptors in the Nonhuman Primate Retina.
by: Luk H. Vandenberghe, et al.
Published: (2013-01-01) -
Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina
by: Chandler, LC, et al.
Published: (2021)